GLP-1 drugs linked to osteoporosis, new research shows
WBRZ • • health
Key Points:
- New research links GLP-1 weight loss medications, used for obesity and Type 2 diabetes, to up to a 30% increased risk of osteoporosis, likely due to rapid weight loss affecting bone density.
- There is no direct biological evidence that GLP-1 drugs damage bone tissue; the increased risk is attributed to mechanical unloading from loss of body and muscle mass combined with nutritional deficiencies.
- Patients taking GLP-1 medications often consume less protein, calcium, and vitamin D, which may contribute to accelerated bone loss.
- Osteoporosis, a condition causing weakened bones and fractures, is a significant health concern, especially for older women.
- Experts recommend strength training and proper nutrition to help maintain bone health while using GLP-1 weight loss drugs.
